Rationale and design of the Corrie Lipids Program: Impact of a digital health-enabled implementation initiative to improve lipid management.
Allison W Peng, Caroline F Plott, Sohail Zahid...
https://pubmed.ncbi.nlm.nih.gov/41935556Actively Recruiting
Led by Johns Hopkins University · Updated on 2026-03-18
1000
Participants Needed
1
Research Sites
26 weeks
Total Duration
J
Johns Hopkins University
Lead Sponsor
A
Amgen
Collaborating Sponsor
This research aims to evaluate the Corrie Lipids Program, a digital health initiative designed to improve lipid-lowering treatment in adults with uncontrolled LDL cholesterol and high risk of atherosclerotic cardiovascular disease (ASCVD). The study focuses on addressing gaps in care by combining a patient smartphone app, clinician education, and integration into clinical workflows. Researchers will assess its impact on LDL cholesterol goal achievement, app use, prescribing patterns, and monitoring using the RE-AIM framework across multiple centers. Participants will receive access to the Corrie Lipids Digital Health Program, which includes a smartphone app providing LDL cholesterol tracking, medication reminders, and educational content. Clinicians also receive training and coaching to support guideline-based lipid management. The study will track outcomes at 6 and 12 months, including LDL cholesterol goal attainment, app engagement, therapy prescribing rates, and clinician program use. During the study, adults will be monitored for LDL cholesterol levels and app usage. Researchers will collect data on prescriptions, lab tests, and clinician involvement in the program. Participants must have a smartphone and be able to use the app. The study will last at least 12 months, with assessments at 6 and 12 months to understand the program's effectiveness, adoption, and maintenance over time.
CONDITIONS
Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - 12 months
Participants use the Corrie Lipids Digital Health Program app to track LDL cholesterol, receive medication reminders, and access educational materials while clinicians support guideline-directed lipid management.
Participants engage with the app and clinical support throughout the program; follow-up assessments at 6 months and 12 months
Total: 1 location
1
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States, 21287
Actively Recruiting
F
Francoise Marvel, MD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Allison W Peng, Caroline F Plott, Sohail Zahid...
https://pubmed.ncbi.nlm.nih.gov/41935556